Skip to main content
≥99.0% HPLC Verified • SEPA Bank & Crypto • Min. Order €220
≥99.0% Lot SL-2026-113
Cagrilintide + Semaglutide 2.5mg + 2.5mg — ≥99.0% analytical research vial
≥99.0%
Analytical Purity
24–48h Dispatch
CH/EU Cold-Chain
SL-2026-113
Active Batch Lot
Metabolic & Incretin Research • In stock — Ready to ship

Cagrilintide + Semaglutide (2.5mg + 2.5mg)

€88 2.5mg + 2.5mg • EUR

Co-formulated research blend pairing long-acting amylin analogue Cagrilintide (2.5 mg) with GLP-1 receptor agonist Semaglutide (2.5 mg) for investigating dual satiety and pancreatic endocrine signaling.

Chemical & Registry Specifications
CAS Registry Number 1415456-99-3 / 910463-68-2
Molecular Formula C194H312N54O59S2 + C187H291N45O59
Molecular Weight 4409.04 g/mol & 4113.58 g/mol
Counterion / Form Acetate lyophilized blend
Sequence / Structural Class Co-formulated acylated Amylin analogue + acylated GLP-1(7-37) analogue
Primary Biological Target / Pathway Dual Amylin/Calcitonin (AMYR/CTR) + GLP-1R agonism
Cold-chain dispatch: CH 1–2d (Free) • EU 2–4d (€12, Free >€150) Shipping & returns
Min. order €220.00 • Payment via SEPA Bank Transfer (EUR) (request IBAN via LiveChat/email) or Crypto (BTC, ETH, USDT, USDC, SOL, XMR).

Scientific Profile & Research Key Points: Cagrilintide + Semaglutide

Co-formulated research blend pairing long-acting amylin analogue Cagrilintide (2.5 mg) with GLP-1 receptor agonist Semaglutide (2.5 mg) for investigating dual satiety and pancreatic endocrine signaling.

Complementary AMYR/CTR + GLP-1R receptor activation
Independent RP-HPLC quantitation of both acylated chains
Dispatched under strict cold-chain thermal protection
Primary Literature Reference Frias J.P. et al., The Lancet (2023) — Co-administration of cagrilintide and semaglutide in metabolic models (PMID: 37364590)
View on PubMed ↗

Active Batch Release Specifications (Lot SL-2026-113)

Analytical release verification for current Cagrilintide + Semaglutide (2.5mg + 2.5mg) inventory

Open Full Batch Registry
Batch Lot # Release Date Analytical Method Purity Spec Endotoxin (LAL) Moisture
SL-2026-113 2026-10-28 Gradient RP-HPLC (Multi-Peak Resolution) + ESI-MS ≥99.0% (Resolved Constituent Peaks) <0.5 EU/mg <2.8% (Karl Fischer)

Laboratory Solubilization & Storage Protocol

Recommended Solvent / Handling

Sterile 0.9% Bacteriostatic Water or sterile neutral PBS buffer

Temperature & Stability

Store lyophilized at -20°C; keep reconstituted solution at 2°C–8°C and avoid freezing.

Cagrilintide + Semaglutide — Technical Questions & Answers

How are the individual constituents of Cagrilintide + Semaglutide verified in a single vial?

Because co-lyophilized blends contain multiple sequences with distinct retention times, Lot SL-2026-113 is evaluated via gradient RP-HPLC to resolve each constituent peak independently, paired with ESI-MS mass confirmation (4409.04 g/mol & 4113.58 g/mol).

How do you calculate working stock aliquots for a multi-component blend like Cagrilintide + Semaglutide?

Calculate each active constituent separately based on its labeled mass ratio (2.5mg + 2.5mg) divided by total diluent volume added. For example, adding 2.0 mL of sterile diluent yields proportional mg/mL concentrations for every component simultaneously.

What primary pathways are investigated using Cagrilintide + Semaglutide?

Investigators study Cagrilintide + Semaglutide in Dual Amylin/Calcitonin (AMYR/CTR) + GLP-1R agonism models. Primary published literature context: Frias J.P. et al., The Lancet (2023) — Co-administration of cagrilintide and semaglutide in metabolic models (PMID: 37364590). All lots are supplied strictly for in-vitro laboratory experimentation.

Research Use Only (RUO): Cagrilintide + Semaglutide is supplied strictly for laboratory in-vitro experimentation and analytical investigation by qualified personnel. Not for human or veterinary administration.

Related Scientific Monographs

Peer-reviewed mechanism summaries and analytical protocols

All monographs (44)

Related Metabolic & Incretin Research Compounds

View category →
≥99.0%
5-Amino-1MQ 10 mg — ≥99.0% Research Vial
5-Amino-1MQ
10 mg In stock
CAS 42464-96-0
MW: 286.11 g/mol
€58
≥99.0%
Adipotide 5 mg — ≥99.0% Research Vial
Adipotide
5 mg In stock
CAS 859216-15-2
MW: 2555.20 g/mol
€55
≥99.0%
AICAR 50 mg — ≥99.0% Research Vial
AICAR
50 mg In stock
CAS 2627-69-2
MW: 258.23 g/mol
€48
≥99.0%
AOD-9604 5 mg — ≥99.0% Research Vial
AOD-9604
5 mg In stock
CAS 221231-10-3
MW: 1815.08 g/mol
€44

Your Research Cart

0 items selected • Min. order €220

SEPA Bank Transfer & Crypto (BTC, ETH, USDT, USDC, SOL, XMR)
Min €220

Your cart is empty

Browse our catalog of research peptides and reagents (minimum order €220).

Browse Catalog